Effect of sulphur mustard on human skin cell lines with differential agent sensitivity

Journal of Applied Toxicology

Volumn 25, Issue 2, 2005, Pages 115-128

  Simpson, Rachel ^a   Lindsay, Christopher D ^a  

^a Biomedical Sciences   (United Kingdom)

Author keywords

Buthionine sulphoximine; Cell cycle; Human skin; Sulphur mustard; Viability

Indexed keywords

3 INDOLEMETHANOL; ACICLOVIR; APHIDICOLIN; BUTHIONINE SULFOXIMINE; HYDROXYUREA; INDIRUBIN; INDIRUBIN 3 MONOXIME; MIMOSINE; MUSTARD GAS; OLOMOUCINE; PROTEINASE INHIBITOR; RAPAMYCIN; STAUROSPORINE; THIOESTER; TRICHOSTATIN A; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL LINE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SKIN CELL;

BUTHIONINE SULFOXIMINE; CELL CYCLE; CELL LINE; CELL SURVIVAL; CHEMICAL WARFARE AGENTS; ENZYME INHIBITORS; FLOW CYTOMETRY; GLUTATHIONE; HUMANS; KERATINOCYTES; MUSTARD GAS; SENSITIVITY AND SPECIFICITY; SKIN;

EID: 16844376237     PISSN: 0260437X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jat.1044     Document Type: Article

References (56)

1. Andrew DJ, Lindsay CD. 1998a. Protection of human upper respiratory tract cell lines against sulphur mustard toxicity by hexamethylenetetramine (HMT). Hum. Exp. Toxicol. 17: 373-379.
2. Andrew DJ, Lindsay CD. 1998b. Protection of upper respiratory tract cell lines against sulphur mustard by glutathione esters. Hum. Exp. Toxicol. 17: 387-395.
3. Armstrong JS, Steinauer KK, Hornung B, Irish JM, Lecane P, Birrell GW, Peehl DM, Know SJ. 2002. Role of glutathione depletion and reactive oxygen species generation in apoptotic signalling in a human B lymphoma cell line. Cell Death Differ. 9: 252-263.
4. Bell LM, Lannon CL, Yhap M, Pyesmany AF, Henry M, Laybolt K, Riddell DC, van Velzen D. 1999. Drug resistance in leukemia and lymphoma III. Adv. Exp. Med. Biol. 457: 289-296.
5. Bootsma D. 2001. The 'Dutch DNA Repair group' in retrospect. Mutat. Res. 485: 37-41.
6. Brooks P, Lawley PD. 1963. Effects of alkylating agents on T2 and T4 bacteriophage. Biochem. J. 89: 138-144.
7. Brown RF, Rice P. 1997. Histopathological changes in yucatan minipig skin following challenge with sulphur mustard. A sequential study of the first 24 h. Int. J. Exp. Pathol. 78: 9-20.
8. Cioe L, Mukhopadhyay S, Rovera G. 1992. Selective-inhibition of proliferation in V-ABL-transformed and BCR-ABL-transformed cells by a nucleoside analogue. J. Biol. Chem. 267: 22178-22182.
9. 1 cell cycle arrest of human breast cancer cells independent of estrogen receptor signalling. J. Biol. Chem. 273: 3838-3847.
10. Cram EJ, Liu BD, Bjeldanes LF, Firestone GL. 2001. Indole-3-carbinol inhibits CDK6 expression in human MCF-7 breast cancer cells by disrupting sp1 transcription factor interactions with a composite element in the CDK6 promoter. J. Biol. Chem. 276: 22332-22340.
11. Doyle A, Griffiths JB, Newell DG. 1996. Cell + Tissue Culture: Laboratory Procedures. John Wiley: Chichester; Section 4E: 3.3.
12. Erickson LC, Laurent G, Sharkey NA, Kohn KW. 1980. DNA cross-linking and monoadduct repair in nitrosourea-treated human tumour cells. Nature 288: 727-729.
13. Fox M, Scott M. 1980. The genetic toxicology of nitrogen and sulphur mustard. Mutat. Res. 75: 131-168.
14. Furet P, Caravatti G, Lydon N, Priestle JP, Sowadski JM, Trinks U, Traxler P. 1995. Modelling study of protein kinase inhibitors: binding mode of staurosporine and origin of the selectivity of CGP 52411. J. Compul. Aid. Mol. Des. 9: 465-472.
15. Gillies RJ, Didier N, Denton M. 1986. Determination of cell number in monolayer cultures. Anal. Biochem. 159: 109-113
16. Gorczya W, Gong J, Ardelt B, Traganos F, Darzynkiewicz Z. 1993. The cell-cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various anti-tumour agents. Cancer Res. 53: 3186-3192.
17. Griffiths GD, Lindsay CD, Upshall DG. 1994. Examination of the toxicity of several protein toxins of plant origin using bovine pulmonary endothelial cells. Toxicology 90: 11-27.
18. Gross CL, Innace JK, Hovatter RC, Meier HL, Smith WJ. 1993. Biochemical manipulation of intracellular glutathione levels influences cytotoxicity to isolated human lymphocytes by sulphur mustard. Cell Biol. Toxicol. 9: 259-268.
19. Haber LF. 1986. The Poisonous Cloud: Chemical Warfare in the First World War. Oxford University Press: Oxford.
20. Hendricks SP, Matthews CK. 1998. Differential effects of hydroxyurea upon deoxyribonucleoside triphosphate pools, analyzed with vaccinia virus ribonucleotide reductase. J. Biol. Chem. 273: 29519-29523.
21. Huffman BD, Hanauskeabel HM, Flint A, Lalande M. 1991. A new class of reversible inhibitors. Cytometry 12: 26-32.
22. Inkoshi J, Katagiri M, Arima S. 1999. Neuronal differentiation of neuro 2a cells by inhibitors of cell cycle progression trichostatin A and butyrolactone. Biochem. Biophys. Res. Commun. 256: 372-376.
23. Klassen CD, Amdur MO, Doull J. 1986. Casarett and Doull's Toxicology: The Basic Science of Poisons. Macmillan Publishing: New York.
24. Lee SE, Mitchell RA, Cheng A, Hendrickson EA. 1997. Evidence for DNA-PK-dependent and -independent DNA double-strand break repair pathways in mammalian cells as a function of the cell cycle. Mol. Cell Biol. 17: 1425-1433.
25. Lindsay CD, Hambrook JL. 1997. Protection of A549 cells against the toxic effects of sulphur mustard by hexamethylenetetramine. Hum. Exp. Toxicol. 16: 106-114.
26. Lindsay CD, Hambrook JL. 1998. Diisopropylglutathione ester protects A549 cells from the cytotoxic effects of sulphur mustard. Hum. Exp. Toxicol. 17: 606-612.
27. Lindsay CD, Hambrook JL, Smith CN, Rice P. 1996. Histological assessment of the effects of percutaneous exposure of sulphur mustard in an in vitro human skin system and the therapeutic properties of protease inhibitors. Symposium paper, In Medical Defense Biosciences Review, vol. II. US Army Medical Research and Development Command: Baltimore; 899-908.
28. Lindsay CD, Hambrook JL, Lailey AF. 1997. Monoisopropylglutathione ester protects A547 cells from the cytotoxic effects of sulphur mustard. Hum. Exp. Toxicol. 16: 636-644.
29. Marko D, Schatzle S, Friedel A, Genzlinger A, Zankl H, Meijer L, Eisenbrand G. 2001. Inhibition of cyclin-dependent kinase 1 (CDK1) by indirubin derivatives in human tumour cells. Br. J. Cancer 84: 283-289.
30. Maynard RL. 1987. A medical review of chemical warfare agents. Technical Paper No. 484. CEDE: Porton Down.
31. Miura M, Sasaki T, Takasaki Y. 1996. Characterization of x-ray-induced immunostaining of proliferating cell nuclear antigen in human diploid fibroblasts. Radiat. Res. 145: 75-80.
32. 1/S-phase growth arrest in lymphocytes-T. J. Biol. Chem. 268: 3734-3738.
33. Murnane JC, Byfield JE. 1981. Irreparable DNA cross-links and mammalian cell lethality with bifunctional alkylating agents. Chem. Biol. Interact. 38: 75-86.
34. Mutomba MC, Wang CC. 1996. Effects of aphidicolin and hydroxyurea on the cell cycle and differentiation of trypanosoma brucei blood stream forms. Parasitology 80: 89-102.
35. Naghii MR. 2002. Sulfur mustard intoxication, oxidative stress, and antioxidants. Mil. Med. 167: 573-575.
36. Ormerod MG. 1996. Analysis of DNA - general methods. In Flow Cytometry: a Practical Approach. Ormerod MG (ed.). IRL Press: Oxford; 19-135.
37. Rice P, Brown RFR. 1999. The development of lewisite vapour induced lesions in the domestic white pig. Int. J. Exp. Pathol. 80: 59-67.
38. Ruegg UT, Burgess GM. 1989. Staurosporine, K-252 and UCN-01: potent nonspecific inhibitors of protein kinases. Trends Pharmacol. Sci. 10: 218-220.
39. Schutte B, Nieland L, Engeland MV, Henfling MER, Meijer L, Ramaekers FCS. 1997. The effect of the cyclin-dependent kinase inhibitor olomoucine on cell cycle kinetics. Exp. Cell. Res. 236: 4-15.
40. Smith ML, Seo YR. 2002. p53 regulation of DNA excision repair pathways. Mutagenesis 17: 149-156.
41. Smith WJ, Sanders KM, Gales YA, Gross CL. 1991. Flow cytometric analysis by vesicating agents in human cells in vitro. J. Toxicol. Cut. Ocul. Toxicol. 10: 33-42.
42. Smith CN, Lindsay CD, Upshall DG. 1997. Presence of methenamine/ glutathione mixtures reduces the cytotoxic effect of sulphur mustard. Hum. Exp. Toxicol. 16: 247-253.
43. Smith CN, Lindsay CD, Hambrook JL. 2001. An in vitro comparison of the cytotoxicity of sulphur mustard in melanoma and keratinocyte cell lines. Hum. Exp. Toxicol. 20: 483-490.
44. Sparfel L, Langouet S, Fautrel A, Salles B, Guillouzo A. 2002. Investigations on the effects of oltipraz on the nucleotide excision repair in the liver. Biochem. Pharm. 63: 745-749.
45. Swe M, Bay BH, Sit K. 1996. Interphase and M-phase oral KB carcinoma cells are targeted in staurosporine-induced apoptosis. Cancer Lett. 104: 145-152.
46. Tomkinson AE, Mackey ZB. 1998. Structure and function of mammalian DNA ligases. Mutat. Res. 407: 1-9.
47. Tuteja N, Tuteja R. 2001. Unraveling DNA repair in humans: molecular mechanisms and consequences of DNA repair defect. Crit. Rev. Biochem. Mol. Biol. 36: 261-290.
48. Vogt RF, Dannenberg Jr AM, Schofield BH, Hynes NA, Papirmeister B. 1984. Pathogenesis of skin lesions caused by sulphur mustard. Fundam. Appl. Toxicol. 4: S71-S83.
49. Wagner ED, Rayburn AL, Anderson D, Plewa MJ. 1998. Analysis of mutagens with single cell gel electrophoresis, flow cytometry and forward mutation assays in an isolated clone of chinese hamster ovary cells. Environ. Mol. Mutagen. 32: 360-368.
50. Wang JYJ. 1998. Cellular responses to DNA damage. Curr. Opin. Cell Biol. 10: 240-247.
51. Wang T. 1996. Cellular DNA Polymerases. In DNA Replication in Eukaryotic Cells, DePamphilis, LM (ed.). Cold Spring Harbour Laboratory Press: Cold Spring Harbour; 461-493.
52. Wood RD, Shivjii MKK. 1997. Which DNA polymerases are used for DNA-repair in eukaryotes? Carcinogenesis 18: 605-610.
53. Xu H, Zhang P, Liu L, Lee MYWT. 2001. A novel PCNA-binding motif identified by the panning of a random peptide display library. Biochemistry 40: 4512-4520.
54. 2+/ calmodulin-independent protein kinase II. J. Neurochem. 56: 294-298.
55. Yarbro JW. 1992. Mechanism of action of hydroxyurea. Semin. Oncol. 19: 1-10.
56. 1 arrest through down-regulation of cyclin E and CDK2 expression. Cell Struct. Funct. 24: 457-463.